WHO ICTRP trial
Salmeterol / fluticasone propionate for inflammation in COPD
ChiCTR-TNC-11001270 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TNC-11001270 |
|---|---|
| Public title | Salmeterol / fluticasone propionate for inflammation in COPD |
| Scientific title | Salmeterol / fluticasone propionate for inflammation in COPD |
| Primary sponsor | The Second Affiliated Hospital of the Third Military Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | IV (Phase IV study) |
| Countries | China |
| Conditions | chronic obstructive pulmonary disease |
| Interventions | 1:salmeterol / fluticasone propionate 50/500ug Bid for 12 weeks |
| Registration date | Mar 25, 2011 |
| Target size | 1:21 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: